Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Hepatitis delta infection among persons living with HIV in Europe
for EuroSIDA and SHCS
Internal Medicine
University of Bern
Stichting HIV Monitoring
Karolinska Institutet
University of Copenhagen
University of Zurich
University of Bonn
University College London
Research output
:
Contribution to journal
›
Article
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatitis delta infection among persons living with HIV in Europe'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Europe
100%
People Living with HIV (PLHIV)
100%
Hepatitis delta Virus
100%
Hepatitis delta Infection
100%
Confidence Interval
22%
Hepatocellular Carcinoma
16%
Virus Infection
16%
Co-infection
16%
Liver-related Mortality
16%
High Prevalence
11%
Overall Mortality
11%
Hepatitis B Surface Antigen (HBsAg)
11%
HIV Cohort
11%
People Who Inject Drugs
11%
Clinical Outcomes
5%
Severe Disease
5%
Demographic Characteristics
5%
Clinical Characteristics
5%
Liver
5%
Adjusted Hazard Ratio
5%
Multivariable Cox Regression
5%
Virus RNA
5%
Cumulative Incidence
5%
Virus Replication
5%
Viral Hepatitis
5%
Antiretroviral Therapy
5%
Virus-neutralizing Antibody
5%
Anti-hepatitis
5%
Descriptive Statistics
5%
Infection-related Mortality
5%
Cause-specific
5%
EuroSIDA
5%
Epidemiological Trends
5%
Injectable Drugs
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Hepatitis Delta Virus
100%
Hepatitis D
100%
Prevalence
29%
Hepatocellular Carcinoma
17%
Virus Infection
17%
Mixed Infection
17%
Hepatitis B Antigen
11%
Hazard Ratio
5%
Proportional Hazards Model
5%
Cohort Analysis
5%
Virus RNA
5%
Cumulative Incidence
5%
Hepatitis Virus
5%
Virus Replication
5%
Virus Antibody
5%
Antiretroviral Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis Delta Virus
100%
Delta Agent Hepatitis
100%
Prevalence
29%
Virus Infection
17%
Liver Cell Carcinoma
17%
Mixed Infection
17%
Hepatitis B Antigen
11%
Cohort Study
5%
Virus Hepatitis
5%
Virus RNA
5%
Virus Antibody
5%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Hepatitis Delta Virus
100%
Hepatitis D
100%
Prevalence
29%
Viral Disease
17%
Coinfection
17%
HBsAg
11%
Hepatitis B Antigen
11%
RNA Virus
5%
Viral Replication
5%
Virus Antibody
5%
Hepatitis Virus
5%
Mathematics
Confidence Interval
100%
Proportional Hazards Model
25%
Hazard Ratio
25%
Median
25%
Interquartile Range
25%
Descriptive Statistics
25%